Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

Parkinson’s Foundation Welcomes Two New Board Members

Peter Goldman and Joshua Raskin Join Board of Directors

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Chicago entrepreneur Peter Goldman and New York financial analyst Joshua Raskin to its Board of Directors.

“Peter and Joshua bring valuable business and philanthropic experience that will further advance the Parkinson’s Foundation’s mission to serve the one million Americans and ten million people worldwide living with this disease,” said John W. Kozyak, Esq., Chairman of the Board of the Parkinson’s Foundation.

Peter Goldman

Goldman is managing partner of Lakeshore Sport & Fitness in Chicago, which owns and operates businesses in the Chicago area focused on hospitality, health and wellness. Before becoming an entrepreneur, Goldman worked for Sam Zell in real estate investing and McKinsey & Company as a management consultant. He has served on several non-profit boards including the Auxiliary Board of the Art Institute of Chicago, where he was a vice president and created a new annual signature fundraising event. 

“I am excited to join the Parkinson’s Foundation board at this critical time,” Goldman said. “The Parkinson’s Foundation’s mission to make life better for people with Parkinson’s is more urgent than ever with 60,000 new cases being diagnosed every year.”

Joshua Raskin

For the past 18 years, Raskin has served as managing director at Barclay's Capital, where he coordinates coverage of the healthcare services sector in the equity research department. Prior to this, he was a managing director at Lehman Brothers for nine years. In 2017, Raskin formed Nephron Research, an independent research boutique focused on healthcare. He has a personal connection to Parkinson’s in his immediate family.

“The fight against Parkinson’s disease and the mission of finding a cure are of deep importance to me, particularly in light of my family history,” Raskin said. “I remain committed to the Parkinson’s community in my new role on the Parkinson’s Foundation board of directors.”

A complete list of the Parkinson’s Foundation’s Board of Directors is available at www.parkinson.org/board.

About the Parkinson’s Foundation

The Parkinson’s Foundation makes life better for people with Parkinson’s disease by improving care and advancing research toward a cure. In everything we do, we build on the energy, experience, and passion of our global Parkinson’s community. For more information, visit www.parkinson.org or call (800) 4PD-INFO (473-4636).

About Parkinson’s Disease

Affecting an estimated one million Americans and 10 million worldwide, Parkinson’s disease is the second-most common neurodegenerative disease after Alzheimer’s and is the 14th-leading cause of death in the United States. It is associated with a progressive loss of motor control (e.g., shaking or tremor at rest and lack of facial expression), as well as non-motor symptoms (e.g., depression and anxiety). There is no cure for Parkinson’s and 60,000 new cases are diagnosed each year in the United States alone.

Tuesday, October 24, 2017
Parkinson’s Foundation Announces New Podcast With Research, Findings And Advice For Patients, Healthcare Professionals, And General Community
Tuesday, August 1, 2017

'Substantial Matters: Life and Science of Parkinson's' Podcast Now Available Online

Parkinson’s Foundation Appoints Sean Kramer as Chief Development Officer
Tuesday, July 11, 2017

NEW YORK & MIAMI — The Parkinson’s Foundation today announced its hiring of Sean Kramer as Senior Vice President, Chief Development Officer. The noted non-profit leader will oversee fundraising initiatives for the national organization, working from its offices in New York and Miami.

The Parkinson’s Foundation’s Fall Moving Day® Walks Fund Local Parkinson’s Programs
Thursday, June 8, 2017

Seven Cities Receive Community Grants 

Parkinson’s Foundation Mourns the Loss of Tom Isaacs
Thursday, June 8, 2017

The Parkinson’s Foundation mourns the loss of Tom Isaacs, a dear friend and renowned global advocate for the Parkinson’s community. Tom passed away on May 31 at the age of 49.

Tom was diagnosed with young onset Parkinson’s more than 20 years ago. He quickly became active in the fight against Parkinson’s in his native UK and as part of the global community.

Parkinson’s Foundation to Host “World Without Parkinson’s” Symposium on Thursday, June 1 to Mark 60th Anniversary
Wednesday, May 31, 2017

Scientific Progress in Next 20 Years Due to Outpace the Last 200

Parkinson’s Foundation Welcomes New Patient Advisors
Wednesday, May 24, 2017

Five New Members Added to Advisory Council to Improve Lives of People Living With Parkinson’s

New York, NY, and Miami, FL — The Parkinson’s Foundation is pleased to welcome five new members to its People with Parkinson’s Advisory Council.  The appointments reflect the foundation’s ongoing commitment to engage with the community in its work to create a world without Parkinson’s disease.

Fifth Annual Celebrate Spring Boston Raises More Than $30,000 for Parkinson’s Foundation
Thursday, May 11, 2017

Boston Area Residents Inspire Fellow Young Professionals to End Parkinson’s

Parkinson’s Foundation Welcomes Paul H. Nathan to Board of Directors
Wednesday, May 3, 2017

New York, NY and Miami, FL — The Parkinson’s Foundation is pleased to announce the election of financial services executive Paul H. Nathan of San Francisco, CA, to its Board of Directors. The appointment was announced following a meeting of the board on April 27.

Parkinson’s Foundation to Host “World Without Parkinson’s” Scientific Symposium on June 1 in NYC
Friday, April 21, 2017

The Parkinson’s Foundation invites health innovators to join World Without Parkinson’s on Thursday, June 1 in New York, NY. The cutting-edge scientific event marks the 200th anniversary of James Parkinson’s, “An Essay on the Shaking Palsy.”

FDA Allows Marketing of a Genetic Test for Medical Conditions Including Parkinson’s
Thursday, April 6, 2017

Earlier today, the US Food and Drug Administration (FDA) announced that it will allow direct marketing to consumers of a genetic test that identifies predispositions for 10 medical conditions, including Parkinson’s. Such tests are referred to as direct-to-consumer or DTC.

Pages

mail icon

Subscribe to get the latest news on treatments, research and other updates.